cannabis patient care
|
vol. 3 no. 1 cannapatientcare.com
10
data focus
Nerve Pain
Patient s who selec ted ner ve pain as their primar y symp-
tom equaled 977 sessions. Of those sessions, 32.9 repor ted
using THC, 16.21 repor ted THC A , 9.72 repor ted CBD, 5.02 re-
por ted THCV, 2.79 repor ted CBDA , and 0.03 repor ted CBDV in
their produc t .
SPECIFIC CONSUMPTION METHOD FOR PATIENTS
REPORTING NERVE PAIN
CONSUMPTION
51.4%
*Included
6.6%
Pipe
13.8%
Vap Pen
5.3%
Joint
8%
Bong
2.1%
Vaporize
6.7%
Gummy
1.9%
Other
1.6%
Tincture
2.6%
Others
PRODUCT TYPE FOR PATIENTS REPORTING NERVE PAIN
CONSUMPTION
6.4%
Bong
5.6%
Other
74.4%
*Included
1%
Resin
19.2%
Flower
0.4%
Shatter
3.3%
Other
0.1%
Kief
1.4%
Wax
0.1%
Hash
OVERALL RATING FOR PATIENTS REPORTING NERVE PAIN
33.2%
Score of 5
2.4%
Score of 1
32.5%
Score of 4
15.6%
Score of 0
13.4%
Score of 3
3%
Score of 2
CONSUMPTION METHOD FOR PATIENTS REPORTING NERVE PAIN
80.3%
Inhaling
17.7%
Orally
1.9%
Topical
*Included means the patient did not report a specific
product type
*Included means the patient did not report a specific
consumption method
